Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma. | Front Pharmacol | 2023 | 37205910 | PubTator, text mining | PubMed |
| LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. | Blood Adv | 2023 | 37205853 | PubTator, text mining | PubMed |
| Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles. | Commun Med (Lond) | 2023 | 37198246 | PubTator, text mining | PubMed |
| Association of social deprivation with survival in younger adult patients with AML: an Alliance study. | Blood Adv | 2023 | 37196637 | PubTator, text mining | PubMed |
| Clinically Aggressive Uterine Epithelioid Leiomyosarcoma with Rhabdomyoblastic Differentiation and High Proliferation Rate: A Case Report. | Am J Case Rep | 2023 | 37190674 | PubTator, text mining | PubMed |
| Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. | Cancers (Basel) | 2023 | 37190237 | PubTator, text mining | PubMed |
| What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach. | Cancers (Basel) | 2023 | 37190176 | PubTator, text mining | PubMed |
| Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia. | Biomedicines | 2023 | 37189716 | PubTator, text mining | PubMed |
| Molecular and biologic biomarkers of Ewing sarcoma: A systematic review. | J Bone Oncol | 2023 | 37180735 | PubTator, text mining | PubMed |
| Autosomal recessive congenital cataract is associated with a novel 4-bp splicing deletion mutation in a novel C10orf71 human gene. | Hum Genomics | 2023 | 37179318 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications. | Cancers (Basel) | 2023 | 37173979 | PubTator, text mining | PubMed |
| Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial. | Exp Hematol Oncol | 2023 | 37173750 | PubTator, text mining | PubMed |
| Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. | Blood Cancer J | 2023 | 37173322 | PubTator, text mining | PubMed |
| Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML. | Blood | 2023 | 37172199 | PubTator, text mining | PubMed |
| A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial. | Blood Adv | 2023 | 37171402 | PubTator, text mining | PubMed |
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia. | Cold Spring Harb Mol Case Stud | 2023 | 37160316 | PubTator, text mining | PubMed |
| Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. | Cell Stem Cell | 2023 | 37146579 | PubTator, text mining | PubMed |
| Circulating Cell-Free Tumor Deoxyribonucleic Acid Analysis as a Tool for the Diagnosis and Monitoring of Pediatric Solid Tumors. | Turk Arch Pediatr | 2023 | 37144257 | PubTator, text mining | PubMed |
| Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3. | Sci Rep | 2023 | 37142644 | PubTator, text mining | PubMed |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. | Blood Adv | 2023 | 37142255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=29